Literature DB >> 3130492

Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.

F G Falkner1, B Moss.   

Abstract

Mycophenolic acid, an inhibitor of purine metabolism, was shown to block the replication of vaccinia virus in normal cell lines. This observation led to the development of a dominant one-step plaque selection system, based on expression of the Escherichia coli gpt gene, for the isolation of recombinant vaccinia viruses. Synthesis of xanthine-guanine phosphoribosyltransferase enabled only the recombinant viruses to form large plaques in a selective medium containing mycophenolic acid, xanthine, and hypoxanthine. To utilize the selection system efficiently, we constructed a series of plasmids that contain the E. coli gpt gene and allow insertion of foreign genes into multiple unique restriction endonuclease sites in all three reading frames between the translation initiation codon of a strong late promoter and synthetic translation termination sequences. The selection-expression cassette is flanked by vaccinia virus DNA that directs homologous recombination into the virus genome. The new vectors allow high-level expression of complete or partial open reading frames and rapid construction of recombinant viruses by facilitating the cloning steps and by simplifying their isolation. The system was tested by cloning the E. coli beta-galactosidase gene; in 24 h, this enzyme accounted for approximately 3.5% of the total infected-cell protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130492      PMCID: PMC253265     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Non-producer human cells induced by murine sarcoma virus.

Authors:  J S Rhim; H Y Cho; R J Huebner
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Dideoxy sequencing method using denatured plasmid templates.

Authors:  M Hattori; Y Sakaki
Journal:  Anal Biochem       Date:  1986-02-01       Impact factor: 3.365

4.  In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals.

Authors:  M A Cochran; C Puckett; B Moss
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

5.  Mapping of a gene coding for a major late structural polypeptide on the vaccinia virus genome.

Authors:  R Wittek; M Hänggi; G Hiller
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

6.  New versatile plasmid vectors for expression of hybrid proteins coded by a cloned gene fused to lacZ gene sequences encoding an enzymatically active carboxy-terminal portion of beta-galactosidase.

Authors:  S K Shapira; J Chou; F V Richaud; M J Casadaban
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

7.  Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.

Authors:  R M Buller; G L Smith; K Cremer; A L Notkins; B Moss
Journal:  Nature       Date:  1985 Oct 31-Nov 6       Impact factor: 49.962

8.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription.

Authors:  C Bertholet; R Drillien; R Wittek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.

Authors:  D Panicali; S W Davis; R L Weinberg; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

View more
  143 in total

1.  Cytoplasmic RNA modulators of an inside-out signal-transduction cascade.

Authors:  M Blind; W Kolanus; M Famulok
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Recombinant vaccinia viruses. Design, generation, and isolation.

Authors:  C C Broder; P L Earl
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

3.  Identification of the amino acid sequence in Sindbis virus nsP4 that binds to the promoter for the synthesis of the subgenomic RNA.

Authors:  Mei-Ling Li; Victor Stollar
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

4.  An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse.

Authors:  P C Turner; R W Moyer
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.

Authors:  J F Rodriguez; G L Smith
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

6.  Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.

Authors:  L Gritz; A Destree; N Cormier; E Day; V Stallard; T Caiazzo; G Mazzara; D Panicali
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Characterization of ectromelia virus deficient in EVM036, the homolog of vaccinia virus F13L, and its application for rapid generation of recombinant viruses.

Authors:  Felicia Roscoe; Ren-Huan Xu; Luis J Sigal
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

8.  Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.

Authors:  Flavio Da Fonseca; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

9.  Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.

Authors:  Yue Peng; Fan-ching Lin; Paulo H Verardi; Leslie A Jones; Tilahun D Yilma
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine.

Authors:  D E Hassett; R C Condit
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.